All data as of Apr 30, 2026. Prices in EUR unless noted. TradingView tickers provided per ETF. No price predictions — thesis + conditions only.
| Index | MarketVector Global Defense Industry |
| Holdings | ~100 |
| TER | 0.55% p.a. |
| AUM | €7.27B |
| Replication | Full physical |
| Type | Accumulating — no dividends paid out |
| Launch | Mar 2023 |
| Domicile | Ireland (UCITS) |
No single company typically >10%. Diversified across US & European primes.
| 52W Low | €44.14 |
| 52W High | €64.51 |
| Current (Apr 30) | ~€55.80 |
| From 52W High | −13.5% |
| Position in Range | 57% |
Pulled back ~13.5% from 52W high. Mid-range entry. YTD return still strong (+65% over prior year from low).
| Driver | Effect |
|---|---|
| Geopolitical escalation | ↑ Strong |
| NATO budget announcements | ↑ Strong |
| US defense budgets | ↑ Strong |
| Peace negotiations | ↓ Sharp |
| Rate hikes (discounts future earnings) | ↓ Mild |
| USD/EUR (30% of holdings in EUR) | Mixed |
Aerospace/defense names appear in:
Practically independent. No meaningful overlap with any core or tech ETF. This is a pure defense bet.
Deploy €215. VIX 18.64 — entry permitted. Pullback from ATH creates reasonable entry. Watch DFEN.DE on TradingView. No stop required for long-term thesis, but if price drops below €44 (52W low), reassess.
Daily: geopolitical headlines (Hormuz, NATO). Weekly: sector price vs. benchmark. Quarterly: review NATO budget commitments and order books of top holdings.
| Index | iSTOXX FactSet Breakthrough Healthcare |
| Holdings | ~100 |
| TER | 0.40% p.a. |
| AUM | €831M |
| Replication | Sampling |
| Type | Accumulating |
| Launch | Sep 2016 |
| Domicile | Ireland (UCITS) |
| 52W Low | ~$6.43 |
| 52W High | ~$9.46 |
| NAV (Jan 7) | $9.45 |
| EUR listing (Feb 13) | €7.53 |
| Note | Healthcare had pullback Feb–Apr on GLP-1/obesity drug concerns. Verify current price in TR before entry. |
| Driver | Effect |
|---|---|
| FDA approvals / trial data | ↑ Strong |
| Aging demographics | ↑ Structural |
| Rate cuts (small-cap relief) | ↑ Moderate |
| Drug pricing legislation | ↓ Sharp |
| GLP-1 device disruption | ↓ Some holdings |
| Economic recession | ~Neutral (healthcare demand stable) |
Some overlap with broad market ETFs on sector level, but the holdings are innovation-focused (not big pharma) — very different names. Low effective overlap with core ETFs.
Deploy €215. Verify current price on HEAL.MI or 2B78.DE before executing — price may have shifted since Jan 2026. If EUR price is below €8.00, this represents a pullback from ATH — favorable entry. GLP-1 concern = short-term noise on long thesis.
Monthly: major FDA decisions. Quarterly: GLP-1/obesity drug impact on device holdings (Dexcom, Insulet). Annually: sector allocation review vs. demographic tailwinds.
| Index | MSCI World Energy (developed markets only) |
| Holdings | ~100 |
| TER | 0.25% p.a. |
| AUM | €1.73B |
| Replication | Full physical |
| Type | Accumulating |
| Launch | Mar 2016 |
| Note | Developed markets only — no EM oil names |
| 52W Low | €40.72 |
| 52W High | €66.92 |
| Current (Apr 18) | ~€56.72 |
| From 52W High | −15.3% |
| Position in Range | 61% |
Hormuz closure pushed oil to $106 but ETF has pulled back ~15% from 52W high. Indicates supply disruption premium already partially priced in, with some retracement.
| Driver | Effect |
|---|---|
| Oil price (primary driver) | ↑↑ Dominant |
| Hormuz status | ↑ Critical |
| USD strength (oil priced in USD) | ↑ Moderate |
| Global GDP/demand | ↑ Moderate |
| Hormuz reopens | ↓↓ Severe |
| Recession | ↓ Demand destruction |
Small overlap with broad market ETFs, but at negligible weight. Effectively a pure energy position. Low correlation to tech cluster. This is a diversifying position.
Deploy €215. Current −15% from 52W high while oil catalyst remains active. This is the highest urgency of the three cleared positions given Hormuz is live. Set a mental exit review: if oil drops below $80 or Hormuz reopens, reassess position. Not a permanent hold — this is tactical.
Daily: oil price (Brent/WTI), Hormuz news. Weekly: XDW0.DE price vs. oil correlation. Monthly: IEA/OPEC supply reports. Exit trigger: Hormuz reopening announcement.
These 7 ETFs are the foundation of the EU market strategy. No action in Phase 1 — analysis is for understanding and future deployment preparation. Savings plans activate Phase 3+.
| Index | S&P 500 — 500 largest US companies |
| Holdings | 503 (full replication) |
| TER | 0.07% p.a. — benchmark low |
| AUM | €119.9B — largest UCITS ETF |
| Sector Top Weight | Technology ~31% / Financials ~13% |
| Type | Accumulating |
Top 10 holdings represent ~33% of total weight. Heavy Magnificent 7 concentration.
| 52W Low | $594.50 |
| 52W High | $770.62 |
| Current (Apr 30) | ~$766.47 |
| From 52W High | −0.5% (near ATH) |
| Position in Range | 98% |
| Driver | Effect |
|---|---|
| US corporate earnings | ↑ Primary |
| Fed rate policy | Mixed (cuts = ↑ usually) |
| USD strength vs EUR | ↑ NAV in USD (check EUR hedge) |
| Recession | ↓ Short-term |
| AI/Tech spending cycle | ↑ 31% tech weight |
CRITICAL: If you hold S&P 500 + MSCI World + ACWI + Nasdaq-100 simultaneously, you own the same companies 4 times. In Phase 3, pick ONE core broad index. Don't stack all four.
Do not buy now. Near ATH. Role: monthly savings plan, Phase 3, recurring fixed amount. DCA removes ATH timing concern entirely. Current price is irrelevant for long-term savings plan logic.
Quarterly: review savings plan amount vs. income change. Annual: rebalance check. Nothing else needed. Set and forget.
| Index | Nasdaq-100 — 100 largest non-financial Nasdaq stocks |
| Holdings | 102 (full replication) |
| TER | 0.30% p.a. |
| AUM | ~€8.3B (EQAC share class) |
| Sector Top Weight | Technology ~60% / Consumer Discret ~17% |
| Key Rule | No financials — banks excluded from index |
Higher concentration than S&P 500. Top 10 ≈ 50%+ of total weight. More volatile, more upside in bull markets, more downside in corrections.
| 52W Low | $400.00 |
| 52W High | $651.30 |
| Current (Apr 30) | ~$624.40 |
| From 52W High | −4.1% |
| Position in Range | 89% |
| Driver | Effect |
|---|---|
| AI investment cycle | ↑↑ Major |
| Rate cuts | ↑ Growth stocks re-rate |
| Rate hikes | ↓ Growth stocks de-rate |
| Tech earnings (AAPL/MSFT/NVDA) | ↑ Dominant driver |
| VIX spike | ↓ Higher beta than SPX |
Highest overlap product in the watchlist. If you hold EQQQ + S&P 500 IT + XAIX, you're tripling up on NVDA, AAPL, MSFT. Check overlap map before combining.
Not both. Before Phase 3 activation, decide: S&P 500 OR Nasdaq-100 as core index. Nasdaq-100 has higher return but higher volatility. For a beginner savings plan, S&P 500 is the more durable choice. Revisit this when Phase 3 activates.
Same as S&P 500. Quarterly earnings watch on top 5 holdings (NVDA particularly). If AI capex narrative breaks, this reacts hardest.
| Index | MSCI World — ~1,400 stocks, 23 developed markets |
| Holdings | ~1,398 (full replication) |
| TER | 0.20% p.a. |
| AUM | ~€135B |
| Geography | US 70% · Japan 6% · UK 4% · France 3% · Canada 3% |
| Type | Accumulating |
| 52W Low | $104.44 |
| 52W High | $137.88 |
| Current (Apr 29) | ~$136.03 |
| From 52W High | −1.3% (near ATH) |
| Position in Range | 95% |
| Driver | Effect |
|---|---|
| US market (70% weight) | ↑ Dominant |
| JPY/USD (Japan 6%) | ↓ Yen weakness hurts |
| EUR/USD (for EUR investor) | Mixed (hedged options exist) |
| Global growth outlook | ↑ Moderate |
MSCI World + S&P 500 together = massive double-counting. MSCI World + Nasdaq-100 + ACWI = triple-counting AAPL/MSFT/NVDA. Pick ONE broad core.
The strongest case as a single core index for EU investors. More diversified than pure S&P 500 at reasonable cost (0.20%). If Phase 3 plan is one core index, IWDA is the most defensible choice. Discuss with grandfather before Phase 3 design.
| Index | MSCI ACWI — 23 developed + 24 emerging markets |
| Holdings | ~2,900 |
| TER | 0.20% p.a. |
| AUM | ~€26–27B |
| EM Exposure | ~10–11% (China, India, Taiwan, Korea) |
| Type | Accumulating |
| 52W Low | ~€76.83 |
| 52W High | ~€114.22 |
| Current (Apr 8) | ~€110.62 |
| From 52W High | ~−3.1% |
| Note | Check SSAC.L/ISAC.DE for current price — Apr 8 data. |
| Driver | Effect |
|---|---|
| US market (63% weight) | ↑ Dominant |
| EM currency moves | Mixed |
| China policy / data | Moderate (3.5% weight) |
| India growth | ↑ Growing driver |
| USD strength | Negative for EM allocation |
ACWI + MSCI World + S&P 500 together is near-complete triple overlap. In Phase 3, pick ONE. ACWI is the most complete, MSCI World is simpler, S&P 500 is cheapest with highest historical return.
Only choose this over MSCI World if you have conviction on emerging market growth (India specifically). Otherwise the EM component adds volatility without proportional return benefit. Monitor: India GDP growth, China property sector, Taiwan geopolitics.
| Index | STOXX Europe 600 — 600 European companies, 17 countries |
| Holdings | 600 (full replication) |
| TER | 0.07% p.a. — tied lowest in class |
| AUM | ~€7–8B |
| Geography | UK 22% · France 16% · Switzerland 14% · Germany 13% |
| Type | Accumulating · EUR denominated (no FX risk) |
| 52W Range | Check CS1.DE in TradingView |
| Current | Verify current in TR |
| STOXX 600 Index | ~520–540 range (Apr 2026) |
| YTD 2026 | Strong — Europe outperforming US in H1 2026 |
| Driver | Effect |
|---|---|
| ECB rate decisions | Cuts = ↑ |
| EUR/USD | EUR ↑ = good for EUR investor |
| Defense budgets (continent-wide) | ↑ Strong |
| Energy prices (Shell, Total) | Mixed |
| German industrial output | Moderate driver (13% weight) |
Low overlap with US-heavy ETFs. This provides genuine geographic diversification. The only EUR-denominated broad market option in the list.
As a Spain-based EUR earner, this is uniquely valuable — your salary and living costs are EUR, so EUR-denominated equity returns compound without currency drag. Consider in Phase 3 alongside one US-focused core index.
| Index | DAX — 40 largest German companies by market cap |
| Holdings | 40 (full replication) |
| TER | 0.09% p.a. — near cheapest |
| AUM | €6.79B |
| Geography | 100% Germany |
| DAX Note | Total return index — dividends reinvested in index itself |
SAP alone is 14% of this ETF. High concentration in auto (BMW/VW), industrial (Siemens/Infineon), and chemicals (BASF). Very different profile from US ETFs.
| 52W Low (Feb data) | ~€179.76 |
| 52W High (Feb data) | ~€239.10 |
| As of Feb 20 | ~€235.05 |
| Note | Data from Feb 2026 — check DBXD.DE in TradingView for current. DAX hit new ATH above 24,000 in 2026. |
| Driver | Effect |
|---|---|
| German industrial output | ↑ Primary |
| China auto demand (BMW/VW ~25% China revenue) | Mixed (China slowdown) |
| ECB rate cuts | ↑ Industrial re-rating |
| Energy prices | ↑ Costs for BASF/Chemicals |
| Defense spending (Airbus/Rheinmetall) | ↑ Strong |
Holding STOXX 600 AND DAX = double-counting German names. Choose one or the other.
Lower priority than STOXX 600 unless you develop a specific Germany conviction thesis. 40-stock concentration increases single-country risk significantly. SAP at 14% is a silent bet on one company.
| Index | MSCI Emerging Markets — 24 EM countries |
| Holdings | ~1,400 |
| TER | 0.20% p.a. (competitive) |
| AUM | ~€5–6B |
| Geography | China 27% · India 18% · Taiwan 18% · Korea 12% |
| Type | Accumulating |
TSMC appears here AND in Semiconductors ETF. China ~27% = geopolitical concentration risk.
| EM Index (XMME reference) | 52W: €49.35–€75.14 |
| Current EM (Apr 21) | ~€73.99 |
| Note | Price is for similar EM ETF — verify PAEM.PA current price in TR. |
| Driver | Effect |
|---|---|
| China economic data | Major (27% weight) |
| India GDP growth | ↑ Growing driver |
| USD strength | ↓ EM debt costs rise |
| Fed rate hikes | ↓ Capital flight from EM |
| Commodity prices | ↑ Many EM = commodity exporters |
| Geopolitics (Taiwan) | ↓ Black swan risk |
If you hold ACWI, you already have ~10–11% EM exposure. Holding EM separately on top of ACWI = doubling the EM bet. Only add separately if you want explicit EM overweight.
Skip if holding ACWI. Add if holding MSCI World and wanting explicit EM exposure. Phase 3 decision: World + EM separately (customized tilt), or ACWI (built-in EM). Don't stack both routes.
All 5 tech ETFs are near 52-week highs or ATH. Entry trigger: 15–20% pullback from current levels. Current macro context (tech near ATH, semis on 17-day record rally) confirms: watching only.
| Index | MSCI ACWI IMI Semiconductors & Semi Equipment (ESG) |
| Holdings | ~60–80 |
| TER | 0.35% p.a. |
| AUM | €2.96B |
| Includes EM | Yes — Taiwan (TSMC), Korea (Samsung) included |
| ESG Screened | Removes controversial weapons, tobacco etc. |
NVIDIA + TSMC + Broadcom = ~40% of this ETF. High concentration in 3 names.
| 52W Low | $6.15 |
| 52W High | $17.06 |
| Current (Apr 28) | ~$16.17 (near ATH) |
| From 52W High | −5.2% |
| Position in Range | 93% |
| Entry trigger | $13.60–14.50 (15–20% pullback) |
17-day record rally per macro context. 52W range of $6.15→$17.06 indicates the semis rally was enormous this year. Near ATH — no entry.
| Driver | Effect |
|---|---|
| AI capex spending | ↑↑ Dominant |
| Data center buildout | ↑ Strong |
| US-China tech war | ↓ ASML/Taiwan exposure |
| VIX spike (high-beta) | ↓↓ Sells off hard |
| Rate hikes | ↓ Growth multiple compresses |
| NVDA earnings | ↑ 14% weight = major lever |
Entry trigger: SEMI.AS drops to $13.60–14.50 range. Do not chase the current rally. Set a price alert on TradingView at $14.50. This is the highest-quality entry in the tech cluster — pure semiconductor exposure is cleaner than broad IT or AI/Big Data.
Weekly: NVDA price (proxy for semis sentiment). Monthly: TSMC earnings (most important semiconductor data point globally). Quarterly: US-China chip export control updates.
| Index | S&P 500 IT Sector — US IT companies only |
| Holdings | ~70–80 |
| TER | 0.15% p.a. — cheapest tech ETF |
| AUM | ~€4–5B |
| Geography | 100% US (S&P 500 IT sector) |
| GICS Definition | Software, hardware, semiconductors, IT services |
AAPL + MSFT + NVDA = ~64% of this ETF. This is almost entirely a 3-stock bet.
| Current Status | Near ATH (confirmed macro context) |
| Entry Trigger | 15–20% pullback from ATH |
| TradingView | QDVE.DE for EUR price, IUIT.L for USD |
| Driver | Effect |
|---|---|
| AAPL/MSFT/NVDA earnings | ↑↑ Dominant (64% weight) |
| AI infrastructure spending | ↑ Strong |
| Rate hikes | ↓↓ Growth multiple compression |
| USD/EUR | US-only exposure matters for EUR investor |
Highest overlap with most other tech ETFs. If you hold S&P 500 IT + Nasdaq-100 + XAIX simultaneously, you own AAPL/MSFT/NVDA 3 times with identical thesis.
Lowest cost tech option (0.15%), but highest AAPL/MSFT concentration. If choosing ONE tech ETF for Phase 3+, the Semiconductors ETF has a purer thesis and less overlap with existing core positions. This is redundant if holding S&P 500 core.
| Index | MSCI World IT — IT sector across 23 developed markets |
| Holdings | ~150–200 |
| TER | 0.25% p.a. |
| AUM | ~€1–2B |
| Geography | US ~85% · Japan ~5% · Netherlands ~4% · Other ~6% |
| Status | Near ATH — confirm XDWT.DE in TR |
| Entry trigger | 15–20% pullback from current |
Virtually identical to S&P 500 IT. ASML adds sensitivity to EU tech regulation and Dutch export controls. SAP adds German enterprise software cycle. Marginal difference in practice.
Least differentiated of the 5 tech ETFs. If entering tech cluster, prioritize: Semiconductors (purer thesis) or AI & Big Data (broader coverage). This is a fallback option only.
| Index | iSTOXX FactSet Automation & Robotics |
| Holdings | ~150 |
| TER | 0.40% p.a. — expensive for the category |
| AUM | €3.74B |
| Geography | US ~45% · Japan ~20% · Europe ~20% · Other ~15% |
| Differentiation | Most geographically balanced tech ETF in list |
Unique feature: heavy Japan (Fanuc, Keyence) and European (ABB, Siemens) industrial automation alongside US names. Least US-concentrated tech ETF in list.
| Current (Apr 30) | ~$16.95 |
| 52W Range | Verify in TR (IRBO.DE) |
| Status | Assumed near-high given tech context |
| Entry Trigger | 15–20% pullback from current |
| Driver | Effect |
|---|---|
| Industrial capex spending | ↑ Primary |
| Labour cost inflation | ↑ Automation ROI improves |
| JPY strength (20% Japan) | ↑ Returns improve for EUR investor |
| Global recession | ↓ Capex is first cut in downturn |
| AI deployment acceleration | ↑ Physical AI buildout |
Lowest overlap with other tech ETFs. Japan and European industrial names provide unique exposure not found elsewhere in the list. Genuinely differentiated.
Most unique of the 5 tech ETFs. Japan industrial + US robotics + European automation = exposure not replicated anywhere else in list. If entering tech cluster after pullback, this + Semiconductors is more diversified than S&P 500 IT + World IT. TER is expensive at 0.40% — account for this in long-term return calculations.
| Index | Nasdaq Yewno Global Innovative Technologies |
| Holdings | ~150–200 |
| TER | 0.35% p.a. |
| AUM | €6.10B — largest AI/tech thematic ETF in Europe |
| Geography | US ~70% · Europe ~15% · Asia ~10% · Other ~5% |
| Index Methodology | AI-selected based on patent/publication proximity to AI/data themes |
Heavier on pure-play AI software (Palantir, Datadog, Snowflake) than the IT ETFs. Includes cloud infrastructure and cybersecurity. Different flavor from semiconductor or pure IT ETFs.
| 52W Low | ~€115.70 |
| 52W High | ~€156.42 |
| Current (Apr 27) | ~€156.42 (AT 52W high) |
| From 52W High | 0% — AT ATH |
| Entry trigger | €125–133 (15–20% pullback) |
| Driver | Effect |
|---|---|
| Enterprise AI adoption rate | ↑↑ Primary |
| Cloud revenue growth | ↑ Strong |
| Rate hikes (growth multiples) | ↓↓ These are high-multiple companies |
| VIX spike | ↓↓ High beta tech |
| AI regulation (EU AI Act) | Mixed — some cost, some moat |
At ATH — most dangerous entry point. The pure-play AI software names (Palantir, Datadog) are genuinely unique vs. other ETFs in the list.
AT 52W HIGH. €156.42 — zero pullback. Set price alert at €133 in TradingView (15% below current). Do not enter. This is the most aggressive buy in the tech cluster — only enter on significant correction with clear thesis confirmation. Pair with Semiconductors if both correct together.
| Index | S&P 500 Capped Financials — US financial sector |
| Holdings | ~70 |
| TER | 0.15% p.a. |
| Geography | 100% US |
| GICS Includes | Banks, insurance, capital markets, consumer finance |
| Driver | Effect |
|---|---|
| Interest rate spread (NIM) | ↑ Primary |
| Yield curve shape | ↑ Steep curve = banks earn more |
| Credit losses / loan defaults | ↓ Major |
| Recession (loan defaults spike) | ↓↓ Severe |
| VIX / market volatility | ↓ Trading desk losses |
Remove from active watch unless one of the conviction catalysts above materializes. Already present at 13% in your S&P 500 core position. No incremental value right now. The grandfather watchlist does not include any financial sector names — noted.
Acknowledged, not analyzed. These instruments exist in the watchlist and will be deployed when Phase 4 conditions are met: demonstrated understanding at L5, grandfather sign-off, portfolio foundation established.
The table below maps which ETFs hold the same core companies. H = High overlap (>50% same holdings by weight), M = Moderate (20–50%), L = Low (<20%), — = Same ETF or negligible.
| CSPX | EQQQ | IWDA | SSAC | SEMI | IUIT | XDWT | XAIX | RBOT | DFEN | HEAL | XDW0 | |
| CSPX (S&P 500) | — | H | H | H | M | H | H | H | M | L | L | L |
| EQQQ (Nasdaq-100) | H | — | H | H | M | H | H | H | M | L | L | L |
| SEMI (Semiconductors) | M | M | M | M | — | H | H | M | M | L | L | L |
| DFEN (Defense) | L | L | L | L | L | L | L | L | L | — | L | L |
| HEAL (Healthcare) | L | L | L | L | L | L | L | L | M | L | — | L |
| XDW0 (Energy) | L | L | L | L | L | L | L | L | L | L | L | — |
9 out of 16 ETFs (non-leveraged) contain NVIDIA. If you hold all 9 simultaneously with equal weight, your actual NVIDIA exposure could exceed 15% of total portfolio. This is a hidden concentration risk that only shows up when you map it explicitly.
| Missing Exposure | Severity | Intentional? | Notes |
|---|---|---|---|
| Bonds / Fixed Income | Moderate | Yes | Growth-only phase. Appropriate for age 23 with 30+ year horizon. Revisit at 35–40. |
| Real Estate (REITs) | Moderate | Yes | Real estate strategy handled via direct property investment, not REITs. |
| Small/Mid Cap exposure | Moderate | Mostly | All ETFs are market-cap weighted = large-cap dominant. STOXX 600 includes some mid/small. No dedicated small-cap play. |
| Commodities (ex-Energy) | Low | Yes | No gold, agriculture, base metals. Energy thesis covers oil sector. Accept for now. |
| Dividend/Value tilt | Low | Yes | All accumulating ETFs, growth-weighted. Appropriate for compounding phase. TradeRepublic 2% savings fills some income role. |
| Latin America / Africa | Low | Yes | Brazil exposure handled via BR market (Inter). Family businesses in BRL. EM ETF has ~5% Brazil. Intentional separation. |
| USD Currency Hedge | Note | Unresolved | Most ETFs are USD-denominated but traded on EUR exchanges (unhedged). A weakening USD (DXY at 98.35 and falling) reduces EUR returns on USD ETFs. Consider EUR-hedged share classes for Core ETFs in Phase 3. |
Capital available: €860.31. Three positions cleared at €215 each. €215 in cash reserve (no thesis). Recommended order based on thesis urgency and opportunity quality:
| Position | Amount | % Portfolio | Category |
|---|---|---|---|
| XDW0 — Energy | €215 | 25% | Sector — Tactical |
| DFEN — Defense | €215 | 25% | Sector — Structural |
| HEAL — Healthcare | €215 | 25% | Sector — Secular |
| Cash Reserve | €215 | 25% | No thesis — Hold |
| Total | €860.31 | 100% | — |
Note: No single position exceeds 25% of current capital → hard rule compliance confirmed. Portfolio is 100% sector ETFs — no broad index exposure yet. Core ETFs deploy in Phase 3 when own EUR capital becomes available.
| Cadence | What to Track | Where | Trigger Action |
|---|---|---|---|
| DAILY | VIX level · Oil price (Brent) · Hormuz news · XDW0 price | TradingView VIX, BNO, XDW0.DE | VIX >25: size down on any new entries. Oil <$80 or Hormuz open: review Energy exit. |
| WEEKLY | DFEN.DE, XDW0.DE, HEAL.MI prices · Tech ETF levels vs. entry triggers · DXY direction | TradingView watchlist | Tech ETF hits 15–20% pullback level → activate grandfather protocol before entry. |
| MONTHLY | Portfolio balance in TradeRepublic · Progress toward +10% unlock target (~€946) · Any new instalment commitments that affect capital availability | TradeRepublic + Financial Ledger chat | Portfolio hits €946 → notify grandfather, prepare tranche 2 deployment thesis. |
| QUARTERLY | Thesis review for all 3 deployed positions · NATO budget news (Defense) · IEA energy reports (Energy) · FDA calendar (Healthcare) | IEA.org, NATO newsroom, FDA.gov | Any thesis breaker event → reassess position. No panic selling — evaluate vs. original thesis. |
| TRIGGERED | Grandfather signal received · VIX >35 · Hormuz reopening confirmed · Any position down >25% from entry | — | Grandfather signal: run full grandfather protocol before executing. VIX >35: no new entries, no panic exit. Position −25%: review thesis vs. entry reasoning — exit only if thesis broken, not price. |
| ANNUAL | Full watchlist review (add/remove ETFs) · Tax position review (Hacienda — capital gains >€1,000) · Phase progress (emergency fund → Phase 2 → Phase 3) | This document + Tax chat | Capital gain realised >€1,000: flag to Tax chat immediately for Hacienda timing. |
| ETF | Ticker in TV | Alert Level | Alert Type |
|---|---|---|---|
| XAIX (AI & Big Data) | XAIX.DE | €133.00 | Price drops below — entry consideration |
| SEMI (Semiconductors) | SEMI.AS | $14.50 | Price drops below — entry consideration |
| RBOT (Automation) | IRBO.DE | 15% below current | Calculate from current price in TR |
| XDW0 (Energy — exit watch) | XDW0.DE | €45.00 | Price drops below — thesis review |
| VIX | VIX | 25.00 | Price rises above — size down protocol |
| VIX | VIX | 35.00 | Price rises above — no new entries |
|
Deploy: Energy first → Defense → Healthcare Hold cash: €215 — no forced entry Watch: Tech at ATH — set alerts, wait for pullback Remove from active watch: Financials (no thesis catalyst) Flag for Phase 3: Pick ONE core index (IWDA recommended) — not all four Critical rule: NVIDIA is in 9 ETFs — audit overlap before stacking tech positions |